Two formats, two very different capabilities
On the surface this looks like a fair fight: two liver-support products, both built on respected botanicals like milk thistle and dandelion. But the real story is about the delivery format, because the format dictates what a formula can physically contain.
Dose is a 60 mL liquid wellness shot built around a 435 mg proprietary blend dissolved in water, orange juice concentrate, and emulsifiers. Mt. Angel D-Tox is an anhydrous (water-free) vegetarian capsule that delivers full clinical-strength milligram doses of each active. That single difference — liquid versus dry encapsulation — is why one formula can cover every phase of detoxification and the other cannot.
How hepatic detoxification actually works
The liver doesn't "filter" toxins like a sieve — it transforms them, converting fat-soluble compounds into water-soluble ones that can leave the body. This happens in three dependent phases, and supporting only one of them can backfire.
Pollutants, metabolic waste, alcohol & medications enter the liver cell.
Cytochrome P450 enzymes oxidize toxins, creating reactive — and more damaging — free radicals.
Both formats can nudge this step. The danger is stopping here.
Reactive intermediates are bound to glutathione for safe disposal — demanding sulfur-bearing precursors.
D-Tox wins: 200 mg NAC fuels glutathione. A liquid shot can't carry stable NAC.
Neutralized, water-soluble compounds exit via bile and the kidneys.
D-Tox: Dandelion, Burdock & Oregon Grape Root drive bile flow and clearance.
Phase I (activation) uses Cytochrome P450 enzymes to oxidize toxins. The catch: this step often produces reactive intermediates that are more damaging than the original compound. Speed up Phase I without supporting what follows and you flood the cell with free radicals.
Phase II (conjugation) binds those reactive intermediates to molecules like glutathione, neutralizing them and making them water-soluble. The pace here depends almost entirely on the availability of conjugating substrates — which is exactly where a liquid shot runs into trouble.
Phase III (elimination) uses ATP-dependent transporters (like P-glycoprotein/MDR1) and bile flow to carry neutralized toxins out for excretion. If bile is sluggish, conjugated toxins back up and cause secondary damage. A complete formula has to address all three.
The missing link: NAC and the Phase II bottleneck
NAC is the rate-limiting precursor the liver uses to rebuild glutathione. Liquids leave it out.
Without a glutathione precursor, Phase II conjugation has no raw material — reactive intermediates can build up.
N-Acetyl Cysteine (NAC) is a stable, well-absorbed precursor to L-cysteine — the rate-limiting building block for glutathione, the body's master antioxidant and primary Phase II conjugate. Oral glutathione itself is poorly absorbed, so supplying NAC is the most reliable route to rebuilding glutathione stores on demand. NAC is the standard hospital antidote for acetaminophen toxicity precisely because it restores depleted glutathione.
Here's the catch for liquids: NAC is intensely sulfurous (it tastes of rotten eggs) and chemically unstable in water. There is essentially no way to put a meaningful, stable dose of NAC into a palatable drinkable shot — so liquid liver formulas, Dose included, simply leave it out. That's a critical gap: a curcumin-forward shot can calm inflammation, but it provides no raw material to fuel Phase II conjugation. D-Tox includes a full 200 mg of NAC in a dry capsule, no flavor or stability compromise required.
The curcumin question: real strength, real limits
The genuine strength
- Colloidal curcumin is highly bioavailable
- Suppresses NF-κB inflammatory signaling
- Pleasant to drink, easy daily compliance
The real limits
- Doesn't replenish glutathione (no NAC)
- No Phase I/II enzyme modulation
- Inflammation control is just one job of many
Credit where it's due — Dose's colloidal curcumin is a clever piece of formulation. Native curcumin is notoriously poorly absorbed, and trapping it in a micellar liquid matrix genuinely boosts bioavailability and helps suppress NF-κB inflammatory signaling. For inflammation alone, that's a legitimate benefit.
But two caveats matter. First, high-bioavailability curcumin is an emerging, documented cause of rare, idiosyncratic, immune-mediated liver injury in genetically susceptible individuals — the very absorption boost that makes it effective is what can trigger it. Second, and more fundamentally, inflammation control is one job. It does nothing to replenish glutathione, regenerate hepatocytes, or stimulate bile flow. Leaning the entire formula on curcumin leaves the rest of the detox cascade unaddressed.
Why the dry capsule wins on payload and stability
Every slice is an active disclosed in milligrams.
Most of the bottle is liquid carrier, hidden in a proprietary blend.
A capsule has no taste limitations and no water to destabilize sensitive actives, so D-Tox can carry the full toolkit at clinical doses:
Milk Thistle (80% Silymarin) stabilizes the hepatocyte membrane, scavenges free radicals, and stimulates RNA polymerase I to drive cellular regeneration. DIM modulates Phase I and Phase II enzymes and supports healthy estrogen metabolism. Dandelion, Burdock, and Oregon Grape Root act as choleretics and cholagogues, stimulating bile flow so conjugated toxins are physically carried out — completing Phase III. A liquid shot, constrained to mild, water-soluble, pleasant-tasting botanicals, can carry only a fraction of this.
Ingredient & payload, head-to-head
The clearest way to see the gap is to line the formulas up. D-Tox discloses every active in exact milligrams; Dose hides individual amounts inside a 435 mg proprietary blend.
Prefer the full detail? Here's the same comparison with exact amounts.
| Detox component | Mt. Angel D-Tox (capsule) | Dose (liquid shot) |
|---|---|---|
| N-Acetyl Cysteine (NAC) | 200 mg — direct glutathione precursor | Absent — too sulfurous & unstable for a drinkable shot |
| Milk Thistle (Silymarin) | 200 mg, standardized to 80% silymarin | Included in a 435 mg proprietary blend (undisclosed amount) |
| Phase I/II modulation (DIM) | 50 mg DIM — AhR & CYP450 modulation | Absent |
| Choleretic / cholagogue botanicals | Dandelion 200 mg + Oregon Grape 200 mg + Burdock 200 mg | Dandelion only (within the blend) |
| Anti-inflammatory anchor | Multi-pathway (Silymarin, DIM, NAC) | Colloidal curcumin (NF-κB inhibition) |
| Label transparency | Every active fully disclosed in milligrams | Proprietary blend — individual doses hidden |
Complete capsule matrix vs. liquid shot
Format isn't a cosmetic choice — it sets the ceiling on what a formula can deliver. Here's how the two paradigms compare on the dimensions that decide real-world detox capability.
| Parameter | Dose (liquid shot) | Mt. Angel D-Tox (capsule) |
|---|---|---|
| Active payload | 435 mg proprietary blend diluted in water, juice & emulsifiers. | Full clinical-strength milligram doses with no water dilution. |
| Phase II / glutathione support | None — no glutathione precursor in the blend. | Direct — high-dose NAC rebuilds glutathione on demand. |
| Compound stability | Aqueous suspension; sensitive actives degrade on the shelf. | Anhydrous capsule protects volatile, sulfur-bearing actives. |
| Pathway coverage | Strong on inflammation (curcumin); thin on Phase II conjugation. | Covers Phase I, II and III in a single formula. |
| Formulation honesty | Proprietary blend hides per-ingredient amounts. | Transparent, itemized milligram label. |
Who each one is for
Consider a liquid shot if…
You mainly want a pleasant-tasting daily curcumin drink for general anti-inflammatory support and prefer not to swallow capsules.
Choose D-Tox if…
You want a focused 30-day cycle that actively supports all three phases of detoxification — with NAC, 80% Silymarin, DIM, and bile-flow botanicals at fully disclosed clinical doses.

